What is a stock summary page? Click here for an overview.
Business Description
Accelerate Diagnostics Inc
NAICS : 325413
SIC : 5047
ISIN : US00430H1023
Share Class Description:
STU:1A80: Ordinary SharesDescription
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.36 | |||||
| Equity-to-Asset | -1.5 | |||||
| Debt-to-Equity | -1.22 | |||||
| Debt-to-EBITDA | -1.52 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -34.1 | |||||
| Beneish M-Score | -6.02 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.4 | |||||
| 3-Year EBITDA Growth Rate | 27.9 | |||||
| 3-Year EPS without NRI Growth Rate | 34.8 | |||||
| 3-Year FCF Growth Rate | 29 | |||||
| 3-Year Book Growth Rate | 50 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.95 | |||||
| 9-Day RSI | 43.87 | |||||
| 14-Day RSI | 42.58 | |||||
| 3-1 Month Momentum % | -9.45 | |||||
| 6-1 Month Momentum % | -20.14 | |||||
| 12-1 Month Momentum % | 21.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 1.15 | |||||
| Days Inventory | 132.01 | |||||
| Days Sales Outstanding | 72.46 | |||||
| Days Payable | 187.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.2 | |||||
| Shareholder Yield % | -60.51 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.25 | |||||
| Operating Margin % | -320.01 | |||||
| Net Margin % | -448.86 | |||||
| FCF Margin % | -231.63 | |||||
| ROA % | -170.68 | |||||
| ROIC % | -223.45 | |||||
| 3-Year ROIIC % | -100.45 | |||||
| ROC (Joel Greenblatt) % | -790.12 | |||||
| ROCE % | -357.21 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.96 | |||||
| EV-to-EBIT | -1.61 | |||||
| EV-to-EBITDA | -1.75 | |||||
| EV-to-Revenue | 5.7 | |||||
| EV-to-FCF | -2.47 | |||||
| Price-to-GF-Value | 0.52 | |||||
| Price-to-Median-PS-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -62.11 | |||||
| FCF Yield % | -92.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Accelerate Diagnostics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 10.917 | ||
| EPS (TTM) (€) | -2.421 | ||
| Beta | -0.72 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.7 | ||
| Volatility % | 78.1 | ||
| 14-Day RSI | 42.58 | ||
| 14-Day ATR (€) | 0.040323 | ||
| 20-Day SMA (€) | 1.0595 | ||
| 12-1 Month Momentum % | 21.05 | ||
| 52-Week Range (€) | 0.68 - 1.91 | ||
| Shares Outstanding (Mil) | 25.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Accelerate Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Accelerate Diagnostics Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Accelerate Diagnostics Inc Frequently Asked Questions
What is Accelerate Diagnostics Inc(STU:1A80)'s stock price today?
The current price of STU:1A80 is €1.04. The 52 week high of STU:1A80 is €1.91 and 52 week low is €0.68.
When is next earnings date of Accelerate Diagnostics Inc(STU:1A80)?
The next earnings date of Accelerate Diagnostics Inc(STU:1A80) is 2025-03-28 Est..
Does Accelerate Diagnostics Inc(STU:1A80) pay dividends? If so, how much?
Accelerate Diagnostics Inc(STU:1A80) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers